Compare PRPO & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | WKHS |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Auto Manufacturing |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 40.3M |
| IPO Year | 2000 | 2008 |
| Metric | PRPO | WKHS |
|---|---|---|
| Price | $23.56 | $2.81 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 40.0K | ★ 114.9K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | 86.92 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $24,049,000.00 | $763,173.00 |
| Revenue This Year | N/A | $89.23 |
| Revenue Next Year | N/A | $28.84 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $13.02 | $0.53 |
| 52 Week High | $33.63 | $11.80 |
| Indicator | PRPO | WKHS |
|---|---|---|
| Relative Strength Index (RSI) | 44.78 | 48.11 |
| Support Level | $22.32 | $2.69 |
| Resistance Level | $24.52 | $3.34 |
| Average True Range (ATR) | 2.34 | 0.20 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 20.12 | 30.79 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.